Capital Flow Monitor · Sponsors · CIK 2070703
US Chemical Technologies, Inc.
3506 CONNECTICUT AVENUE, NW, WASHINGTON, DC, 20008 · 202-963-2550
Other Technology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$30.0M
Sold
$30.0M
% sold
100.0%
Investors
5
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | D ·current | 506(b) | $30.0M | $30.0M | 100.0% | 5 | EDGAR ↗ |
| 2026-01-23 | D | 506(b) | $30.0M | $30.0M | 100.0% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Daniel DePaoli — Executive Officer / Director, Washington, DC
- Ivo Ivanov — Executive Officer, Washington, DC
- Alan Freedman — Director, Washington, DC
-
Dayna Grayson — Director, Washington, DC
4 other raises
- Construct Capital Select Fund II, L.P. $150.0M of $150.0M · 100.0%
- Copia Automation, Inc. $18.0M of $23.1M · 77.9%
- Verve, Inc. $12.8M of $16.4M · 77.7%
- Hadrian Automation, Inc. $131.3M of $151.3M · 86.8%
- Jonathan Crandall — Executive Officer / Director, Washington, DC
- Andrew Kreitz — Director, Washington, DC
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.